Earnings Releases·Nov 5, 2026, 8:30 AM ET

Aemetis — Third Quarter 2026 Earnings Summary

Revenue surged 49% year-over-year to $88.2 million for Q3 2026, while net income turned positive at $5.2 million compared to a $23.7 million loss in Q3 2025; Adjusted EBITDA improved to $24.8 million from a $5.0 million loss.
The company reported a significant reduction in the nine-month net loss to $25.9 million from $71.7 million, driven by a 39% increase in Biogas RNG sales volume and a $24.7 million recognition of Section 45Z tax credits, including an $11.0 million cumulative true-up.
Strategic progress includes the expansion of the dairy digester network to 14 units, the ongoing construction of the mechanical vapor recompression (MVR) system at the Keyes ethanol plant, and the pursuit of a potential IPO for its India subsidiary, Universal Biofuels.
Management outlined a multi-track financing plan to address near-term obligations and fund growth, including advanced preparation for long-term financing of the Keyes plant and the extension of the Series A Preferred Unit redemption date to December 31, 2026.